Axitinib fda approval date?

What was the FDA approval date for axitinib?

Axitinib (Inlyta) received FDA approval on January 27, 2012. [1]

What was axitinib approved for at that time?

At the time of approval, axitinib was indicated for advanced renal cell carcinoma (RCC) after failure of prior systemic therapy. [1]

Where can I verify the approval date?

You can verify the approval date on DrugPatentWatch.com’s drug page for axitinib. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/axitinib